Israel Englander’s Nu Skin NUS Stock Holding History

Israel Englander’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-8,900	Closed	-$737K	–	3726
2014 Q1	$737K	Buy	8,900 +6,600	+287%	+$580K	﹤0.01%	2408
2013 Q4	$318K	Buy	+2,300	New	+$271K	﹤0.01%	2998

Other funds holding NUS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $1.21B AUM 20.39% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Israel Englander's NUS Position: Q2 2026 in Review

Israel Englander sold out of Nu Skin (NUS) in Q2 2026, closing a stake of 110,136 shares — an estimated $802K sold.

Israel Englander first reported a position in NUS in Q3 2013 and held it in 45 quarters. The position peaked at $41.1M in Q4 2022. 162 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

Israel Englander reported no remaining Nu Skin position as of Q2 2026 after selling out during the quarter.
Israel Englander sold 110,136 Nu Skin shares in Q2 2026, an estimated $802K.
Israel Englander first reported a position in Nu Skin in Q3 2013 and held it in 45 quarters.
Israel Englander's Nu Skin position peaked at $41.1M in Q4 2022.
162 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.